Oseltamivir phosphate
Oseltamivir phosphate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Oseltamivir phosphate; Generic name: OSELTAMIVIR PHOSPHATE; Manufacturer: Preferred Pharmaceuticals Inc..
| Brand name | Oseltamivir phosphate |
|---|---|
| Generic name | OSELTAMIVIR PHOSPHATE |
| Manufacturer | Preferred Pharmaceuticals Inc. |
| Used for | 1 INDICATIONS AND USAGE Oseltamivir phosphate for oral suspension is an influenza neuraminidase inhibitor (NAI) indicated for: • Treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. () • Prophylaxis of influenza A and B in patients 1 year and older. () Limitations of Use : • Not a substitute for annual influenza vaccination. () • Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use. () • Not recommended for patients with end-stage renal disease not undergoing dialysis. () 1.1 Treatment of Influenza Oseltamivir phosphate for oral suspe |
| Dosage | 2 DOSAGE AND ADMINISTRATION Treatment of influenza • Adults and adolescents (13 years and older): 75 mg twice daily for 5 days () • Pediatric patients 1 to 12 years of age: Based on weight twice daily for 5 days () • Pediatric patients 2 weeks to less than 1 year of age: 3mg/kg twice daily for 5 days () • Renally impaired adult patients (creatinine clearance greater than 30 to 60 mL/min): Reduce to 30 mg twice daily for 5 days () • Renally impaired adult patients (creatinine clearance greater th |
| Active ingredient(s) | OSELTAMIVIR PHOSPHATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=16fcbcb4-609c-4d4e-a134-013823207dc7 |